PRLD Prelude Therapeutics Incorporated PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Prelude Therapeutics (PRLD) Stock: Buy, Sell, or Hold?

$3.79
+0.03 (+0.80%) ▲
5d: -7.11% 30d: +6.46% 90d: -29.29%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (55%)
Quality Score
43/100
Position
FAIR
30-Day Fair Range
$3.48 – $3.94
Position: FAIR
Forward P/E & Valuation
-6.5x CHEAP
vs 34.9x historical avg
Wall Street Target
$9.20
+144.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.34 / $4.25
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: PRLD is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.

Get Alerted When PRLD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: PRLD is currently trading at $3.79, which is considered fair relative to its 30-day fair value range of $3.48 to $3.94. From a valuation perspective, the stock is trading at a discount (Forward PE: -6.5) compared to its historical average (34.9). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, PRLD is in a downtrend. Immediate support is located at $3.34, while resistance sits at $4.25.

Market Sentiment: PRLD scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.20 (+144.7%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $3.48 - $3.94
Company Quality Score 43/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 54.8%

Trading Range & Key Levels

30-Day Trading Range $3.48 - $3.94
Current vs Trading Range FAIR
Support Level $3.34
Resistance Level $4.25
Current Trend Downtrend
Technical data as of Nov 10, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (37/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 144.7% below Wall St target ($9.20)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -6.48
Wall Street Target $9.20 (+144.7%)
Revenue Growth (YoY) 41.0%
Profit Margin -269.8%
PE vs Historical -6.5 vs 34.9 CHEAP
Share PRLD Analysis

Share this live PRLD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (PRLD)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 13, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages indicate bullish sentiment towards $PRLD, with traders expecting a return to previous price levels despite recent index buying support. No relevant news articles were found.
Key Retail Themes: price levels market sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:34 AM ET
Data refreshes hourly during market hours. Next update: 10:34 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for PRLD.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ARGX
argenx NV ADR
STRONG BUY
23 analysts
$1147 47 HOLD
KYMR
Kymera Therapeutics Inc
STRONG BUY
24 analysts
$145 31 SELL
BNTX
BioNTech SE
BUY
21 analysts
$114 63 BUY
IRD
Opus Genetics, Inc.
STRONG BUY
18 analysts
$13 43 HOLD
MRUS
Merus BV
STRONG BUY
17 analysts
$97 39 SELL

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive PRLD Research Pages
PRLD Technical Chart PRLD Price Prediction PRLD Intrinsic Value DCF PRLD Earnings Date PRLD Investment Advisor PRLD Fair Price Analyzer PRLD Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals